Abstract
A series of novel 5-sulfonyl-indolin-2-ones were designed, synthesized, and screened for their antitumor activity on SGC-7901, A549, HCT116, and ECA-109 cell lines. Four compounds with the most potent antitumor activity were further determined as fibroblast growth factor receptor 2 (FGFR2) inhibitors. Among them, compound 2b was further identified to inhibit HUVECs tube formation.
| Original language | English |
|---|---|
| Pages (from-to) | 1054-1057 |
| Number of pages | 4 |
| Journal | MedChemComm |
| Volume | 2 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2011 |